Rare disease & genomics research
From molecular mechanisms to clinical impact
Uniting genomics, epigenomics and clinical science to decode chromatinopathies.
Building the first European network for chromatinopathy research.
Over two and a half days in İzmir, clinicians, researchers and patient advocates from across Europe come together to establish the first European network dedicated to chromatinopathies — rare genetic disorders caused by changes in the genes that regulate chromatin structure and gene activity.
We warmly invite you to join us on the Aegean coast to share science, build collaborations and shape the future of rare disease research.
This meeting is supported by the ERDERA Networking Support Scheme (NSS).
Uniting genomics, epigenomics and clinical science to decode chromatinopathies.
A pan-European network — connecting research across bordersOrganised by an international, multi-stakeholder consortium with partners from the European Reference Networks (ERNs) and ERDERA, the conference unites expertise across countries and disciplines.
Its aim is to promote patient-centred research, strengthen collaborations, and lay the foundation for future European initiatives in chromatinopathy research.
Abstract submission is now open. Registration is now open.
A preliminary outline — select a day to explore its sessions. The full timetable will follow.
Setting the scientific scene — the molecular basis of chromatin regulation and how its disruption gives rise to chromatinopathies.
Clinical presentation, phenotypic spectrum and diagnostic journeys across the family of chromatinopathy disorders.
Reading the interplay between epigenomic and transcriptomic signals to understand disease mechanisms.
A discussion on establishing a dedicated working group within the ERN-ITHACA framework.
New tools reshaping chromatinopathy research — from single-cell approaches to advanced multi-omics.
Emerging therapeutic strategies, developed hand-in-hand with the patient community.
Centring the voices of patients and families in the research agenda.
A poster session and networking opportunity connecting early-career and established researchers.
A hands-on workshop exploring the practical use and limitations of DNA methylation episignatures.
Applying protein structure prediction to interpret variants and mechanisms in chromatinopathies.
Strategising joint funding applications and durable cross-border collaborations.
Reflections on the meeting and the roadmap for a lasting European chromatinopathy network.
Researchers are invited to submit abstracts presenting original work related to chromatinopathies, rare diseases, epigenetics and associated technologies.
You must first register for the conference in order to submit abstracts
Click a topic to add it to your abstract's keywords.
Registration is required for all participants. The fee schedule is shown below; the live registration portal will open in August 2026 — the form below previews the details we'll ask for.
| Registration category | Early bird | Regular |
|---|---|---|
| Academic / Researcher | €150 | €250 |
| Student (PhD/MSc)* | €100 | €150 |
| Participants from Underrepresented Countries* | €150 | €200 |
| Patient Representatives* | Free | Free |
| Industry | €400 | €500 |
| Invited Speakers | Free | Free |
* Early-bird registration is available until 2 October 2026.
* Participants from Türkiye may register under the “Participants from Underrepresented Countries” category.
Please transfer the registration fee to the bank account below:
After completing your bank transfer, you must email your payment receipt (dekont) to euchromnet2026@gmail.com. Please include your full name and registration category in the message so we can confirm your payment. Your registration is finalised only once the receipt has been received.
Send payment receiptThe registration fee includes:
An optional social dinner may be added later.
Limited funding support may be available for eligible participants, including students, early-career researchers, and participants from underrepresented and under-resourced countries.
Depending on available funding and eligibility criteria.
Applicants seeking funding support must submit an abstract to be eligible for consideration. In addition, applicants should submit:
Applications can also be submitted by email to conference@ibg.edu.tr.
Send emailWe welcome organizations, companies, foundations, and other stakeholders interested in supporting the conference and contributing to the advancement of research and collaboration in the field.
A range of sponsorship opportunities will be available, including opportunities for visibility and engagement before, during, and after the conference.
For sponsorship opportunities and further information, please contact:
Kübra Ünal
✉️ kubra.unal@ibg.edu.tr
The Izmir Biomedicine and Genome Center (IBG) is a leading research institute dedicated to biomedical and genome sciences.
IBG coordinates the Horizon 2020 ERA Chair project RareBoost, strengthening scientific excellence, international collaboration and innovation in rare disease research.
İzmir Biomedicine and Genome Center (IBG) — konferans mekânıLocated on Türkiye's Aegean coast, İzmir is a vibrant city renowned for its rich history, cultural heritage and Mediterranean atmosphere — from ancient ruins and Ottoman-era streets to sunlit bays and a lively seafront.
A curated list of nearby hotels and rates.
İzmir Adnan Menderes Airport (ADB) connections.
Getting to IBG by metro, tram and taxi.
Entry requirements and invitation letters.
Interactive map of the venue and area.
This conference is made possible through the collaboration of leading European rare-disease research organisations and the support of the European Union.
Co-funded by the European Union · Supported by the ERDERA Networking Support Scheme (NSS)